Apnimed annual operating margin
2024
2025
Apnimed's operating margin was −139.91% for fiscal 2025.
View full Apnimed company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −139.91% | +1285.88 pp |
| 2024 | 2024-12-31 | −1,425.79% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −96.89% | −62.19 pp |
| Q2 2025 | 2025-06-30 | −34.69% | — |
| Q1 2025 | 2025-03-31 | −31.97% | — |
Between the periods ended 2024-12-31 and 2025-12-31, Apnimed's operating margin increased from −1,425.79% to −139.91%, a change of +1285.88 percentage points. The latest reported quarter, Q2 2026, shows −96.89%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Apnimed source filings ↗